1140-29-0

Basic information

• Product Name: N,N-diphenylethylenediamine
• Synonyms: N,N'-DIPHENYLETHYLENEDIAMINE;N,N-diphenylethane-1,2-diamine
• CAS NO: 1140-29-0
• Molecular Formula: C₁₄H₁₆N₂
• Molecular Weight: 212.29
• Mol File: 1140-29-0.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N,N-diphenylethylenediamine(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-diphenylethylenediamine(1140-29-0)
• EPA Substance Registry System: N,N-diphenylethylenediamine(1140-29-0)

Safety Data

• Hazardous Substances Data: 1140-29-0(Hazardous Substances Data)

Upstream product

• 36602-06-9 N,N-diphenylamino acetonitrile 
• 122-39-4 diphenylamine 
• 52850-21-2 N,N-diphenyl-β-alanine methyl ester 
• 1333418-02-2 C₁₅H₁₇N₃O 
• 42393-65-7 N-(2-chloroethyl)-N-phenylaniline 
• 64-17-5 ethanol 
• 572-18-9 (1E,2E)-1,2-diphenylethane-1,2-dione bis(phenylhydrazone) 
• 41975-79-5 benzil-hydrazone oxime 
• 33722-46-2 isoamarine 
• 123-51-3 i-Amyl alcohol 
• 861552-39-8 4,5-diphenyl-2,5-dihydro-1H-imidazole-2-thiol 
• 861595-01-9 4,5-diphenyl-2,5-dihydro-1H-imidazol-2-ol 
• 10035-10-6 hydrogen bromide 
• 64-19-7 acetic acid 

Downstream Products

• 1372104-62-5 N-(2-(diphenylamino)ethyl)-2-phenylacetamide 
• 1372104-58-9 N⁽¹⁾-phenethyl-N⁽¹⁾,N⁽¹⁾-diphenylethane-1,2-diamine 
• 1372104-59-0 N⁽¹⁾,N⁽¹⁾-diphenyl-N⁽²⁾-(3-phenylpropyl)ethane-1,2-diamine 
• 1361005-93-7 N-(2-diphenylamino-ethyl)-2-(3-fluoro-4-methanesulfonylamino-phenyl)-propionamide 
• 15747-08-7 oxo bis-(N'-salicylidenato N,N-diphenyl ethylene diamine) vanadium (IV) 
• 86922-19-2 2-Isopropyl-11-oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid (2-diphenylamino-ethyl)-amide 
• 33722-46-2 isoamarine 
• 530-36-9 threo-1,2-diphenyl-2-aminoethan-1-ol 
• 492-70-6 1,2-diphenyl-1,2-ethanediol 
• 947-91-1 Diphenylacetaldehyde 
• 76695-61-9 meso-N,N'-bibenzyl-α,α'-diyl-bis-formamide 

Relevant articles and documents

DUAL INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE AND 5-LIPOXYGENASE

The invention pertains to a novel structure (I) that provides an activity as a dual inhibitor of the enzymes soluble epoxide hydrolase (sEH) and 5-lipoxygenase (5-LOX). The invention pertains to multiple derivatives of the new class of dual inhibitors, their application in medicine, pharmaceutical compositions comprising them as well as to methods for synthesizing the new compounds.

METHODS AND USES OF MELATONIN LIGANDS

The disclosure provides methods and uses for alleviating and/or treating pain including pain disorders using melatonin ligands of Formula I: or pharmaceutically acceptable salts thereof wherein: n is 1 or 2; m is 0, 1 or 2; p is 0, 1, 2, 3, 4, 5, 6, 7 or

Reversal agent and linker variants of reversed chloroquines: Activities against Plasmodium falciparum

We have shown that "reversed chloroquine molecules" constructed from chloroquine-like and resistance "reversal-agent"-like cores can be powerful drugs against malaria (J. Med. Chem. 2006, 49, 5623-5625). Several reversed chloroquines are now presented that probe parameters governing the activities against chloroquine-resistant and chloroquine-sensitive malaria strains. The design is tolerant to linker and reversal agent changes, but a piperazinyl group adjacent to the quinoline, at least for the group of compounds studied here, may be detrimental. 2009 American Chemical Society.